Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Pittsburgh School of Medicine
Pittsburgh, Estados UnidosPublications en collaboration avec des chercheurs de University of Pittsburgh School of Medicine (31)
2024
-
A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis
Hepatology Communications, Vol. 8, Núm. 8
-
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial
Intensive Care Medicine, Vol. 50, Núm. 2, pp. 247-257
-
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma
Biomolecules, Vol. 14, Núm. 6
-
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Molecular Therapy Oncology, Vol. 32, Núm. 2
2023
-
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)
Nature Communications
-
Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study
Intensive Care Medicine, Vol. 49, Núm. 12, pp. 1441-1455
2022
-
Genomic profiling for clinical decision making in lymphoid neoplasms
Blood
-
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis
American Journal of Pathology, Vol. 192, Núm. 12, pp. 1658-1669
-
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
British Journal of Haematology, Vol. 196, Núm. 3, pp. 639-648
-
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood, Vol. 140, Núm. 11, pp. 1229-1253
2021
-
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
Nature Communications, Vol. 12, Núm. 1
-
Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis
Hepatology International, Vol. 15, Núm. 4, pp. 1006-1017
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 7, pp. 757-767
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
2019
-
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Nature Communications, Vol. 10, Núm. 1
-
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
Hepatology Communications, Vol. 3, Núm. 7, pp. 867-882
-
Reduced serum sphingolipids constitute a molecular signature of malnutrition in hospitalized patients with decompensated cirrhosis
Clinical and Translational Gastroenterology, Vol. 10, Núm. 3
2017
-
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients
Oncotarget, Vol. 8, Núm. 1, pp. 1416-1428
-
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6